Marktgröße für Alzheimer-Diagnostika, Marktanteilsanalyse bis 2025-2031
Alzheimers Disease Diagnostic Market Report Analysis
Alzheimers Disease Diagnostic Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbvie Inc.
- TauRx Pharmaceuticals Ltd
- Eli Lilly and Company.
- Alector, Inc.
- Treventis Corporation.
- Accera, Inc.
- Cognition Therapeutics, Inc.
- Biogen
- F. Hoffmann-La Roche Ltd
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Typ
- früh einsetzende Alzheimer-Krankheit
- spät einsetzende Alzheimer-Krankheit
- familiäre Alzheimer-Krankheit
By Diagnostische Tests
- Gentests
- neurologische Untersuchungen
- Mini-Mental-State-Examen
By Endbenutzer
- Krankenhäuser und Kliniken
- Diagnosezentren und Forschungsinstitute
- Sonstige
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For